Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
12/31/24 07:00 | 12/30/24 | BHVN | Health | Drug | Pharmaceutical Preparations | Childs John W | CT | D | 7 | P | 23,054 | 29.38 | 0 | 785 | 14 | 6,511 | I | |||||||||||||||
10/3/24 07:00 | 10/2/24 | BHVN | Health | Drug | Pharmaceutical Preparations | Coric Vlad | CT | DO | CEO | 3 | P | 16,000 | 26.78 | 0 | 598 | 23 | 3,168 | I | ||||||||||||||
9/25/24 07:30 | 9/24/24 | BHVN | Health | Drug | Pharmaceutical Preparations | Bailey Gregory | CT | D | 5 | P | 4,135 | 36.89 | 0 | 112 | 7 | 1,620 | D | |||||||||||||||
6/20/24 07:30 | 6/17/24 | BHVN | Health | Drug | Pharmaceutical Preparations | Car Bruce | CT | O | Chief Sc | 1 | P | 1,007 | 33.58 | 0 | 30 | 999% | 32 | I | ||||||||||||||
10/6/23 07:38 | 10/5/23 | BHVN | Health | Drug | Pharmaceutical Preparations | Buten Matthew | CT | O | CFO | 1 | P | 500 | 22.00 | 0 | 23 | 14 | 189 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |